Table 4 Improvement in A1C and medications after SG
Patients | Type of DM | Timing | A1C | Medications |
|---|---|---|---|---|
Patient 2 | T2D | Pre-LSG | 8.6 | Biphasic insulin 70:30 (Novomix) 40 U daily |
Post-LSG | 6.4 | Linagliptin 5 mg/day | ||
Patient 3 | T2D | Pre-LSG | 8 | Biphasic insulin 70:30 (Novomix) 40 U daily |
Post-LSG | 6.2 | Linagliptin 5 mg/day | ||
Patient 5 | T2D | Pre-LSG | 9 | Biphasic insulin 70:30 (Novomix) 60 U daily |
Post-LSG | 6.7 | Linagliptin 5 mg/day |